Strategies to Improve Pain and Enjoy Life

• Status: Recruiting
• Trial end date: 2021-06-01
• Target enrollment: 0
• Participant gender: All

Summary

In the Strategies to Improve Pain and Enjoy Life (STRIPE) study, the effectiveness of a multicomponent intervention will be tested, compared with usual care, on opioid dose and pain outcomes among patients on high dose (≥ 40 mg morphine equivalent dose) long-term opioid therapy in a randomized controlled trial. This intervention will have 4 components: a) telephone-delivered evidence-based pain self-management training, b) web-based video of successfully tapered patients with motivational interviewing debriefing, c) a voluntary, self-paced opioid taper, and d) opioid and non-opioid prescribing guidance for the patient's primary care provider.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Washington
• Collaborators: Kaiser Permanente; National Institute on Drug Abuse (NIDA)
• Treatments: Analgesics, Opioid

Criteria

Inclusion Criteria:

• age 18-80 years

• receiving care at a Kaiser Washington primary care clinic;

• Chronic Non-Cancer Pain, defined as patient-reported pain on more than half the days in the past 6 months;

• currently on higher-dose long-term opioid therapy, defined as >90 days' supply in the past 180 days with a mean daily dose of 40 mg MED or greater in the past 30 days, as first identified via Kaiser's pharmacy dispensing data and subsequently validated by patient self-report during screening for the trial

• consent to participate in the study arm to which they are randomly assigned

• able to read, speak, and write English adequate for outcome measures

• enrollment in Kaiser for at least 6 months prior and no plans to disenroll over the next year.

Exclusion Criteria:

• receiving treatment for cancer

• enrollment in palliative or hospice care

• use in past year of parenteral, transdermal, or transmucosal opioids

• residing in nursing home or assisted living

• using any implanted device for pain control

• American Psychiatric Association Diagnostic and Statistical Manual 5th edition (DSM-5) Opioid Use Disorder (OUD) according to International Classification Diseases OUD diagnoses in the Electronic Health Record

• psychotic symptoms, psychiatric hospitalization or suicide attempts in the past year

• current suicidal ideation with plan or intent

• dementia diagnosis in Electronic Health Record

• Patients on buprenorphine for any reason